A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia

A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.

Leukemia·2017

A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.

Leukemia·2016

A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome.

Leukemia·2015

Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson.

Leukemia·2013

A pilot pharmacokinetic study of oral azacitidine.

Leukemia·2008

Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies.

Leukemia·2008

How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

Blood·2026

Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).

Blood·2026

Multimodal analysis of CD38 in T-cell Acute Lymphoblastic Leukemia Identifies Combinatorial Therapeutic Strategies.

Blood·2026

CXXC1-dependent IRF4 activity promotes myeloma cell fitness and sustains lenalidomide resistance.

Blood·2026

Epstein-Barr virus-associated chromatin activation and enhancer engagement in T/NK-cell lymphoproliferative diseases.

Blood·2026

Vitamin C promotes differentiation of stress-specific erythroid progenitors in stress erythropoiesis.

Blood·2026

An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.

Neurological research·2026

Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026

Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.

Endocrine-related cancer·2026

Effectiveness of Selective Cyclooxygenase-2 Inhibitors for Postoperative Pain Management Using Multidimensional Pain Assessment: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Anesthesiology·2026

Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.

Cancer cytopathology·2026

PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.

Pakistan journal of pharmaceutical sciences·2026

Related Experiment Videos

A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute

Related Concept Videos

A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.

A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials.

A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome.

Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson.

A pilot pharmacokinetic study of oral azacitidine.

Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies.

How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses.

Technical Considerations in the choice and use of ctDNA for Large B-cell lymphoma (LBCL).

Multimodal analysis of CD38 in T-cell Acute Lymphoblastic Leukemia Identifies Combinatorial Therapeutic Strategies.

CXXC1-dependent IRF4 activity promotes myeloma cell fitness and sustains lenalidomide resistance.

Epstein-Barr virus-associated chromatin activation and enhancer engagement in T/NK-cell lymphoproliferative diseases.

Vitamin C promotes differentiation of stress-specific erythroid progenitors in stress erythropoiesis.

An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.

Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.

Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.

Effectiveness of Selective Cyclooxygenase-2 Inhibitors for Postoperative Pain Management Using Multidimensional Pain Assessment: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.

PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.

Related Experiment Videos

A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute...

Related Concept Videos

Related Articles

A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute